English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 99 Help

Selected(0)Clear Items/Page:    Sort:
Polycyclic polyprenylated acylphloroglucinols from the pericarps of Garcinia multiflora champ. ex Benth. with cytotoxic property Journal article
Cao, Jun, Lyu, Wen Yu, Zhang, Yujia, Su, Zhicheng, Li, Ting, Zhang, Qingwen, Gan, Lishe, Lu, Jin Jian, Lin, Ligen. Polycyclic polyprenylated acylphloroglucinols from the pericarps of Garcinia multiflora champ. ex Benth. with cytotoxic property[J]. Phytochemistry, 2024, 228, 114242.
Authors:  Cao, Jun;  Lyu, Wen Yu;  Zhang, Yujia;  Su, Zhicheng;  Li, Ting; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.2/3.4 | Submit date：2024/09/03
Apoptosis  Cell Cycle Arrest  Clusiaceae  Cytotoxicity  Garcinia Multiflora  Polycyclic Polyprenylated Acylphloroglucinols  
The Interaction of Calcium-Sensing Receptor with KIF11 Enhances Cisplatin Resistance in Lung Adenocarcinoma via BRCA1/cyclin B1 pathway Journal article
Wang, Fuhao, Fu, Xing, Chang, Ming, Wei, Tianzi, Lin, Risheng, Tong, Haibo, Zhang, Xiao, Yuan, Runzhu, Zhou, Zhiqing, Huang, Xin, Zhang, Wei, Su, Wenmei, Lu, Yi, Liang, Zhen, Zhang, Jian. The Interaction of Calcium-Sensing Receptor with KIF11 Enhances Cisplatin Resistance in Lung Adenocarcinoma via BRCA1/cyclin B1 pathway[J]. International Journal of Biological Sciences, 2024, 20(10), 3892-3910.
Authors:  Wang, Fuhao;  Fu, Xing;  Chang, Ming;  Wei, Tianzi;  Lin, Risheng; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.2/8.3 | Submit date：2024/10/10
Brca1  Casr  Chemoresistance  Cyclin B1  Kif11  Lung Adenocarcinoma  
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma Journal article
Zhang, Qi Yi, Ding, Wen, Mo, Jian Shan, Ou-yang, Shu Min, Lin, Zi You, Peng, Ke Ren, Liu, Guo Pin, Lu, Jin Jian, Yue, Pei Bin, Lei, Jin Ping, Wang, Yan Dong, Zhang, Xiao Lei. Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma[J]. ACTA PHARMACOLOGICA SINICA, 2024.
Authors:  Zhang, Qi Yi;  Ding, Wen;  Mo, Jian Shan;  Ou-yang, Shu Min;  Lin, Zi You; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:6.9/7.6 | Submit date：2024/05/16
Acquired Sorafenib-resistance  Antisense Oligonucleotide  Hepatocellular Carcinoma  Stat3  
Paraptosis: a non-classical paradigm of cell death for cancer therapy Journal article
Xu, Chun cao, Lin, Yi fan, Huang, Mu yang, Zhang, Xiao lei, Wang, Pei, Huang, Ming qing, Lu, Jin jian. Paraptosis: a non-classical paradigm of cell death for cancer therapy[J]. Acta Pharmacologica Sinica, 2024, 45(2), 223-237.
Authors:  Xu, Chun cao;  Lin, Yi fan;  Huang, Mu yang;  Zhang, Xiao lei;  Wang, Pei; et al.
Favorite | TC[WOS]:20 TC[Scopus]:17  IF:6.9/7.6 | Submit date：2024/05/16
cancer therapy  endoplasmic reticulum  ER stress  mitochondria  paraptosis  
Paraptosis: a non-classical paradigm of cell death for cancer therapy Review article
2024
Authors:  Xu, Chun cao;  Lin, Yi fan;  Huang, Mu yang;  Zhang, Xiao lei;  Wang, Pei; et al.
Favorite | TC[WOS]:20 TC[Scopus]:17  IF:6.9/7.6 | Submit date：2024/02/22
Cancer Therapy  Endoplasmic Reticulum  Er Stress  Mitochondria  Paraptosis  
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia Journal article
Mo, Jianshan, Deng, Lin, Peng, Keren, Ouyang, Shumin, Ding, Wen, Lou, Linlin, Lin, Ziyou, Zhu, Jianzheng, Li, Jingwei, Zhang, Qiyi, Wang, Pengyan, Wen, Yuanzhen, Chen, Xiaobing, Yue, Peibin, Lu, Jin Jian, Zhu, Kai, Zheng, Yongjiang, Wang, Yuanxiang, Zhang, Xiaolei. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia[J]. Journal of Hematology & Oncology, 2023, 16(1), 15.
Authors:  Mo, Jianshan;  Deng, Lin;  Peng, Keren;  Ouyang, Shumin;  Ding, Wen; et al.
Favorite | TC[WOS]:15 TC[Scopus]:14  IF:29.5/26.9 | Submit date：2023/03/06
Aml  Immunotherapy  Stat3 Inhibitor  Vista  
Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells Journal article
HE, Xinyu, FU, Jiarui, LYU, Wenyu, HUANG, Muyang, MO, Jianshan, CHENG, Yaxin, XU, Yulian, ZHENG, Lijun, ZHANG, Xiaolei, QI, Lu, ZHANG, Lele, ZHENG, Ying, HUANG, Mingqing, NI, Lin, LU, Jinjian. Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells[J]. Chinese Journal of Natural Medicines, 2023, 21(11), 842-851.
Authors:  HE, Xinyu;  FU, Jiarui;  LYU, Wenyu;  HUANG, Muyang;  MO, Jianshan; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.0/3.7 | Submit date：2024/01/10
Bulbocodin c  Bulbocodin d  Cancer  Erk  Natural Products  Stat3  
Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis Journal article
Yu,Jie, Zhong,Bingling, Zhao,Lin, Hou,Ying, Ai,Nana, Lu,Jin Jian, Ge,Wei, Chen,Xiuping. Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis[J]. Drug Resistance Updates, 2023, 70, 100977.
Authors:  Yu,Jie;  Zhong,Bingling;  Zhao,Lin;  Hou,Ying;  Ai,Nana; et al.
Favorite | TC[WOS]:27 TC[Scopus]:28  IF:15.8/18.1 | Submit date：2023/08/03
Drug-resistance  Ferroptosis  Lung Cancer  Mam  Nqo1  
Identification of bulbocodin D and C as novel STAT3 inhibitors and their anticancer effects in cancer cells Conference paper
He, Xinyu, Fu, Jiarui, Huang, Muyang, Lyu, Wenyu, Mo, Jianshan, Cheng, Yaxin, Xu, Yulian, Zheng, Lijun, Zhang, Xiaolei, Qi, Lu, Zhang, Lele, Zheng, Ying, Huang, Mingqing, Ni, Lin, Lu, Jinjian. Identification of bulbocodin D and C as novel STAT3 inhibitors and their anticancer effects in cancer cells[C], 2023.
Authors:  He, Xinyu;  Fu, Jiarui;  Huang, Muyang;  Lyu, Wenyu;  Mo, Jianshan; et al.
Favorite |  | Submit date：2023/08/25
Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer Journal article
Lin,Ziyou, Li,Jingwei, Zhang,Jian, Feng,Weineng, Lu,Jiaye, Ma,Xiaofan, Ding,Wen, Ouyang,Shumin, Lu,Jinjian, Yue,Peibin, Wan,Guohui, Liu,Peiqing, Zhang,Xiaolei. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer[J]. Cancer research, 2023, 83(13), 2187-2207.
Authors:  Lin,Ziyou;  Li,Jingwei;  Zhang,Jian;  Feng,Weineng;  Lu,Jiaye; et al.
Favorite | TC[WOS]:31 TC[Scopus]:30  IF:12.5/11.6 | Submit date：2023/08/03